Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Phase I Study of Bortezomib and Gemcitabine in Elderly Patients With Solid Tumors (X05227)
Authors not listed
Masonic Cancer Center, University of Minnesota · 2007
Abstract
RATIONALE: Bortezomib may stop the growth of solid tumors by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. Drugs used in chemotherapy, such as gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving bortezomib together with gemcitabine may kill more tumor cells.
PURPOSE: This phase I trial is studying the side effects and best dose of bortezomib and gemcitabine in treating older patients with advanced solid tumors.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Anonymous. (2007). Phase I Study of Bortezomib and Gemcitabine in Elderly Patients With Solid Tumors (X05227). <em>Masonic Cancer Center, University of Minnesota</em>. https://clinicaltrials.gov/study/NCT00620295
Vancouver
Anonymous. Phase I Study of Bortezomib and Gemcitabine in Elderly Patients With Solid Tumors (X05227). Masonic Cancer Center, University of Minnesota. 2007.
BibTeX
@misc{anon2007PhaseI,
title = {Phase I Study of Bortezomib and Gemcitabine in Elderly Patients With Solid Tumors (X05227)},
author = {Anonymous},
journal = {Masonic Cancer Center, University of Minnesota},
year = {2007},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Barbara Ann Karmanos Cancer Institute 2008
Open access · US-GOV
Evaluation of Bevacizumab and Weekly Docetaxel in Elderly (≥ 75 Years) Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Case Comprehensive Cancer Center 2015
Open access · US-GOV
A Phase II Trial of Weekly Bortezomib and Dexamethasone With Oral Metronomic Cyclophosphamide in Elderly Patients With Plasma Cell Myeloma
SWOG Cancer Research Network 2001
Open access · US-GOV
Protocol for Assessment of Gemcitabine and Paclitaxel for Metastatic Urothelial Cancer in Patients Aged 70 Years or Older (and in a Cohort of Patients Younger Than 60 Years)
University of Washington 2006
Open access · US-GOV
A Phase II Study of Intermittent Gleevec® (Imatinib Mesylate) and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-Small Cell Lung Cancer
University of Nebraska 2007
Open access · US-GOV
Phase II Study of Weekly Vinorelbine and Paclitaxel in Elderly Patients With Advanced Non-Small Cell Lung Cancer
Jonsson Comprehensive Cancer Center 2010
Open access · US-GOV